Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases
Authors
Ansari-Pour, Naser
Scott, Francis
Welsh, Sarah J.
Parkinson, Christine
Khoja, Leila
Tullett, Mark
Gómez, Julia M. Martínez
Levesque, Mitchell
Jiménez-Sánchez, Alejandro
Riva, Laura
Allinson, Kieren
Corrie, Pippa
Publication Date
2020-08-27Journal Title
Nature Communications
Publisher
Nature Publishing Group UK
Volume
11
Issue
1
Language
en
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Rabbie, R., Ansari-Pour, N., Cast, O., Lau, D., Scott, F., Welsh, S. J., Parkinson, C., et al. (2020). Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases. Nature Communications, 11 (1)https://doi.org/10.1038/s41467-020-18060-0
Abstract
Abstract: Metastatic melanoma carries a poor prognosis despite modern systemic therapies. Understanding the evolution of the disease could help inform patient management. Through whole-genome sequencing of 13 melanoma metastases sampled at autopsy from a treatment naïve patient and by leveraging the analytical power of multi-sample analyses, we reveal evidence of diversification among metastatic lineages. UV-induced mutations dominate the trunk, whereas APOBEC-associated mutations are found in the branches of the evolutionary tree. Multi-sample analyses from a further seven patients confirmed that lineage diversification was pervasive, representing an important mode of melanoma dissemination. Our analyses demonstrate that joint analysis of cancer cell fraction estimates across multiple metastases can uncover previously unrecognised levels of tumour heterogeneity and highlight the limitations of inferring heterogeneity from a single biopsy.
Keywords
Article, /631/67/322, /631/67/1813/1634, /631/67/2329, /631/114/2397, /631/114/2407, /45/22, /45/23, /45/90, /49/39, article
Identifiers
s41467-020-18060-0, 18060
External DOI: https://doi.org/10.1038/s41467-020-18060-0
This record's URL: https://www.repository.cam.ac.uk/handle/1810/309685
Rights
Licence:
https://creativecommons.org/licenses/by/4.0/